Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1982 Jun;13(1):48–52. doi: 10.1007/BF00200200

Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen

Tsuguo Tanaka 1, Hisakazu Yamagishi 1, Neal R Pellis 1,✉, Barry D Kahan 1
PMCID: PMC11039230  PMID: 6760958

Abstract

Rabbits imunized with the immunoprotective TSTA fraction partially purified by preparative isoelectric focusing of 3 M KCl extracts from a chemically induced murine sarcoma, MCA-F, produced specific xenoantisera as assessed by an indirect membrane immunofluorescence assay. Only the immunizing tumor, MCA-F, and not the antigenically distinct MCA-D or MCA-T target cells were stained by the xenoantiserum. Absorption of anti-MCA-F antiserum with the antigenically distinct MCA-D or MCA-T cells did not reduce its capacity to bind to MCA-F cells. The immunofluorescence reaction was competitively inhibited by MCA-F fractions that induced specific immunoprotection: crude 3 M KCl extract, isoelectrically focused TSTA (fraction 15), and intact irradiated MCA-F cells. The TSTA specificity of these xenoantisera suggests that they may provide useful reagents for rapid isolation and characterization of the immunoprotective moiety.

Keywords: Cancer Research, Sarcoma, Target Cell, Tumor Antigen, Immunofluorescence Assay

Footnotes

Abbreviations used: TSTA, tumor-specific transplantation antigens; MCA, 3-methylcholanthrene; MCA-F, MCA-D, MCA-T, methylcholanthrene-induced fibrosarcoma of C3H/HeJ mice; pIEF, preparative isoelectric focusing; PBS, 0.15 M phosphate-buffered saline (pH 7.2); MEM, minimum essential medium; MTD, minimum tumorigenic dose; Fr 15, fraction 15 of pIEF containing TSTA; FI, fluorescence index; FITC, fluorescein isothiocynate

References

  • 1.Allison JP, Pellegrino MA, Ferrone S, Callahan GN, Reisfeld RA. Biologic and chemical characterizations of HLA antigens in human serum. J Immunol. 1977;118:1004. [PubMed] [Google Scholar]
  • 2.Baldwin RW, Barker CR, Embleton MJ, Glaves D, Moore M, Pimm MV. Demonstration of cell surface antigens on chemically induced tumors. Ann NY Acad Sci. 1971;77:268. doi: 10.1111/j.1749-6632.1971.tb35056.x. [DOI] [PubMed] [Google Scholar]
  • 3.Bowen JG, Baldwin RW. Tumor antigens and alloantigens. II. Lack of association of rat hepatoma-D23-specific antigen with β-2 microglobulin. Int J Cancer. 1979;23:833. doi: 10.1002/ijc.2910230615. [DOI] [PubMed] [Google Scholar]
  • 4.Burk KH, Drewinko B, Litchtiger B, Trujillo JM. Cell cycle dependency of human sarcoma-associated tumor antigen expression. Cancer Res. 1976;36:1278. [PubMed] [Google Scholar]
  • 5.Drewinko B, Yang Y. Restriction of CEA synthesis to the stationary phase of growth of cultured human colon carcinoma cells. Exp Cell Res. 1976;101:414. doi: 10.1016/0014-4827(76)90393-1. [DOI] [PubMed] [Google Scholar]
  • 6.Galloway DR, McCabe RP, Pellegrino MA, Ferrone S, Reisfeld RA. Tumor-associated antigens in spent medium of human melanoma cells: Immunochemical characterization with xenoantisera. J Immunol. 1981;126:62. [PubMed] [Google Scholar]
  • 7.Invernizzi G, Parmiani G. Tumor-associated transplantation antigens of chemically induced sarcomata cross reacting with allogenic histocompatibility antigens. Nature. 1975;254:713. doi: 10.1038/254713a0. [DOI] [PubMed] [Google Scholar]
  • 8.Invernizzi G, Carbone G, Meschini A, Parmiani G. Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcoma. J Immunogenet. 1977;4:97. doi: 10.1111/j.1744-313x.1977.tb00619.x. [DOI] [PubMed] [Google Scholar]
  • 9.Macek CM, Kahan BD, Pellis NR. Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay. J Immunol. 1980;125:1639. [PubMed] [Google Scholar]
  • 10.McCabe RP, Ferrone S, Pellegrino MA, Kern DH, Holmes EC, Reisfeld RA. Purification and evaluation of human melanoma-associated antigens. J Natl Cancer Inst. 1978;60:773. doi: 10.1093/jnci/60.4.773. [DOI] [PubMed] [Google Scholar]
  • 11.Natori T, Law LW, Appella E. Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma. Meth A. Cancer Res. 1978;38:359. [PubMed] [Google Scholar]
  • 12.Pellegrino MA, Ferrone S, Pellegrino A. In: Transplantation antigens. Kahan B, Reisfeld R, editors. New York: Academic Press; 1972. pp. 443–452. [Google Scholar]
  • 13.Pellis NR, Kahan BD. Specific tumor immunity induced with soluble materials; restricted range of antigen dose and of challenge tumor load for immunoprotection. J Immunol. 1975;115:1711. [PubMed] [Google Scholar]
  • 14.Pellis NR, Kahan BD. Methods to demonstrate the immunogenicity of soluble tumor specific transplantation antigens. I. The immunoprophylaxis assay. Methods in Cancer Research. 1976;13:291. [Google Scholar]
  • 15.Pellis NR, Kahan BD. Methods to demonstrate the immunogenicity of soluble tumor antigens. II. The local adoptive transfer assay. Methods in Cancer Research. 1978;14:29. [Google Scholar]
  • 16.Pellis NR, Yamagishi H, Macek CM, Kahan BD. Specificity and biological activity of extracted tumor-specific transplantation antigens. Int J Cancer. 1980;26:443. doi: 10.1002/ijc.2910260409. [DOI] [PubMed] [Google Scholar]
  • 17.Pellis NR, Yamagishi H, Shulan DJ, Kahan BD. Use of preparative isoelectric focusing in a sephadex gel slab to separate immunizing and growth facilitating moieties in crude 3 M KCl extract of a murine fibrosarcoma. Cancer Immunol Immunother. 1981;11:53. [Google Scholar]
  • 18.Radola BJ. Isoelectric focusing in layer of granulated cells. II. Preparative isoelectric focusing. Biochim Biophys Acta. 1974;386:181. doi: 10.1016/0005-2795(75)90258-5. [DOI] [PubMed] [Google Scholar]
  • 19.Reisfeld RA, Kahan BD. Biologic and chemical characterization of human histocompatibility antigens. Fed Proc. 1970;29:2034. [PubMed] [Google Scholar]
  • 20.Witz IP. Tumor-bound immunoglobulins: in situ expressions of humoral immunity. Adv Cancer Res. 1977;25:95. [PubMed] [Google Scholar]
  • 21.Wood GW, Gillespie GY. Studies in the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcoma. Int J Cancer. 1975;16:1022. doi: 10.1002/ijc.2910160616. [DOI] [PubMed] [Google Scholar]
  • 22.Wood GW, Tilzer SA, Gollahon KA, Lindsay JM. Association between immunoglobulin and macrophages in primary methylcholanthrene-induced sarcomas. Cancer Res. 1979;39:4588. [PubMed] [Google Scholar]
  • 23.Yamagishi H, Pellis NR, Kahan BD. Tumor-protective and -facilitating antigens from 3 M KCl solubilized tumor extracts. J Surg Res. 1979;26:392. doi: 10.1016/0022-4804(79)90025-8. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES